Articles

OpenURL

Anti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets (with Jason L. Liggett, X Zhang, and T E. Eling), Cancer Letters (2014)

Non-steroidal anti-inflammatory drugs (NSAIDs) are used extensively for analgesic and antipyretic treatments. In addition, NSAIDs...

 

PDF

Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells (with E-Chu Huang, Yi Zhao, Guoxun Chen, Michael F. McEntee, Steven C. Minkin, John P. Biggerstaff, and Jay Whelan), BMC complementary and alternative medicine (2014)

BACKGROUND: Zyflamend, a mixture containing extracts of ten herbs, has shown promise in a variety...

 

OpenURL

Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation (with S U. Kang, J W. Choi, Y S. Shin, S H. Lee, and C H. Kim), Free radical biology & medicine (2014)

Nonsteroidal anti-inflammatory drugs (NSAIDs) are usually used for the treatment of inflammatory diseases. However, certain...

 

OpenURL

The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid, Cancer prevention research (Philadelphia, Pa.) (2013)

The nonsteroidal anti-inflammatory drug tolfenamic acid has been shown to suppress cancer cell growth and...

 

OpenURL

Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells (with J B. Jeong, J Choi, and S H. Lee), Archives of biochemistry and biophysics (2013)

Several studies have shown substantial evidences that non-steroidal anti-inflammatory drugs (NSAIDs) exert anticancer effects by...